FDA NDC Directory · JSON-LD · Markdown

Terazosin

NDC 69452-331 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerBionpharma Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA075667
Dosage form / routeCAPSULE · ORAL
Active ingredientsTERAZOSIN HYDROCHLORIDE (2 mg/1)
Marketing started20240311
Package count2

External sources

Source: openFDA. Public-domain (CC0).